Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

Martek Biosciences Corp - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 14/01/2008
  • Report Title: Martek Biosciences Corp - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 47
Introduction

Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It's research is focused on identifying and creating commercially viable products for the nutraceutical, pharmaceutical and functional foods markets.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Martek's product focus is the development of nutritional products derived from microalgae, fungi and other microbes for the treatment of diseases in the area of inflammation, cognitive function and cardiovascular health. It has developed and patented two fermentable strains of microalgae which produce oils rich in docosahexaenoic acid (DHA).

    A similar patented process was developed for a fungus that produces an oil rich in arachidonic acid, ARA. Both DHA and ARA are important nutrients for optimal infant development. It's product folio includes Neuromins brand DHA supplements containing life'sDHA is a vegetarian source of docosahexaenoic acid, DHA for pregnant women.

    Martek derives majority of its revenues from the product sales of infant formula that contains nutritional oils as well as from the product sales of Neuromins, a DHA dietary supplement. It also generates revenues through contract manufacturing for the production of enzymes, specialty chemicals, vitamins and agricultural specialty products.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic